Loading...
Rising Global Controls And Biosimilar Risks Will Squeeze Margins
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
75.2%7D
4.0%1Y
75.2%7D
4.0%You can edit this narrative until Sep 1 10:12 PM. Then, changes will post as Updates.
You can edit this narrative until Sep 1 10:12 PM. Then, changes will post as Updates.